Does Humira Treat Sarcoidosis? A Look at Off-Label Use and Efficacy
•
4 min read
While not specifically approved by the U.S. Food and Drug Administration (FDA) for sarcoidosis, the tumor necrosis factor (TNF) inhibitor Humira (adalimumab) has been used off-label to treat the condition, especially in cases that are refractory to conventional therapies. In a 2023 meta-analysis of anti-TNF-α agents for sarcoidosis, adalimumab was shown to reduce or stabilize the disease in 60% of patients who received it.
